Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.057 AUD | +5.56% |
|
-3.39% | -48.18% |
06-24 | Imugene Doses First Patient of Bile Tract Cancer in Phase One Clinical Trial; Shares Decline 6% | MT |
04-16 | Imugene Signs Deal to Sell Manufacturing Facility For $6 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.18% | 263M | |
+21.85% | 46.44B | |
+38.90% | 39.1B | |
-8.05% | 38.76B | |
+29.04% | 31.24B | |
-13.75% | 25.8B | |
+10.65% | 25.9B | |
+38.43% | 13.12B | |
-6.92% | 11.32B | |
-12.29% | 10.68B |
- Stock Market
- Equities
- IMU Stock
- News Imugene Limited
- Imugene's Vaxinia Trial Shows Positive Signs